Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

EPA:ALBFR - Euronext Paris - Matif - FR0010202606 - Common Stock - Currency: EUR

241.85  +9.05 (+3.89%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALBFR. ALBFR was compared to 97 industry peers in the Software industry. ALBFR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALBFR shows excellent growth, but is valued quite expensive already. These ratings could make ALBFR a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year ALBFR was profitable.
ALBFR had a positive operating cash flow in the past year.
In the past 5 years ALBFR has always been profitable.
Each year in the past 5 years ALBFR had a positive operating cash flow.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

With an excellent Return On Assets value of 10.30%, ALBFR belongs to the best of the industry, outperforming 85.57% of the companies in the same industry.
ALBFR has a better Return On Equity (20.04%) than 83.51% of its industry peers.
ALBFR's Return On Invested Capital of 8.78% is fine compared to the rest of the industry. ALBFR outperforms 72.16% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBFR is below the industry average of 10.77%.
The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(8.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROIC 8.78%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ALBFR's Profit Margin of 14.36% is fine compared to the rest of the industry. ALBFR outperforms 68.04% of its industry peers.
ALBFR's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 10.56%, ALBFR is doing good in the industry, outperforming 61.86% of the companies in the same industry.
In the last couple of years the Operating Margin of ALBFR has grown nicely.
The Gross Margin of ALBFR (75.67%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

ALBFR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALBFR has more shares outstanding
ALBFR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALBFR has been reduced compared to a year ago.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.55 indicates that ALBFR is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALBFR (7.55) is better than 80.41% of its industry peers.
ALBFR has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.92, ALBFR belongs to the best of the industry, outperforming 80.41% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that ALBFR is not too dependend on debt financing.
The Debt to Equity ratio of ALBFR (0.20) is better than 67.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Altman-Z 7.55
ROIC/WACC1.06
WACC8.31%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.55 indicates that ALBFR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, ALBFR is in the better half of the industry, outperforming 64.95% of the companies in the same industry.
ALBFR has a Quick Ratio of 1.55. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, ALBFR is in the better half of the industry, outperforming 68.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.62%, which is quite impressive.
Measured over the past years, ALBFR shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
Looking at the last year, ALBFR shows a very strong growth in Revenue. The Revenue has grown by 25.69%.
The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%

3.2 Future

ALBFR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.12% yearly.
ALBFR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.06% yearly.
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.24%
Revenue Next 2Y15.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALBFR is valuated quite expensively with a Price/Earnings ratio of 46.51.
ALBFR's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 24.12. ALBFR is valued rather expensively when compared to this.
ALBFR is valuated quite expensively with a Price/Forward Earnings ratio of 40.76.
The rest of the industry has a similar Price/Forward Earnings ratio as ALBFR.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.42, ALBFR is valued quite expensively.
Industry RankSector Rank
PE 46.51
Fwd PE 40.76
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ALBFR's Enterprise Value to EBITDA ratio is in line with the industry average.
65.98% of the companies in the same industry are more expensive than ALBFR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 42.35
EV/EBITDA 46.01
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALBFR does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ALBFR may justify a higher PE ratio.
A more expensive valuation may be justified as ALBFR's earnings are expected to grow with 12.12% in the coming years.
PEG (NY)4.41
PEG (5Y)1.67
EPS Next 2Y12.12%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBFR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIDETRADE

EPA:ALBFR (5/8/2025, 7:00:00 PM)

241.85

+9.05 (+3.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15
Earnings (Next)07-16 2025-07-16
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners36%
Ins Owner ChangeN/A
Market Cap362.77M
Analysts84
Price Target280.5 (15.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.85%
PT rev (3m)1.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.05%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.55%
Revenue NY rev (3m)-3.12%
Valuation
Industry RankSector Rank
PE 46.51
Fwd PE 40.76
P/S 6.6
P/FCF 42.35
P/OCF 37.92
P/B 9.21
P/tB 42.04
EV/EBITDA 46.01
EPS(TTM)5.2
EY2.15%
EPS(NY)5.93
Fwd EY2.45%
FCF(TTM)5.71
FCFY2.36%
OCF(TTM)6.38
OCFY2.64%
SpS36.65
BVpS26.27
TBVpS5.75
PEG (NY)4.41
PEG (5Y)1.67
Profitability
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROCE 11.95%
ROIC 8.78%
ROICexc 18.16%
ROICexgc N/A
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
FCFM 15.58%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Debt/EBITDA 1.09
Cap/Depr 71.02%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 132.6%
Profit Quality 108.49%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 7.55
F-Score7
WACC8.31%
ROIC/WACC1.06
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%
Revenue Next Year16.24%
Revenue Next 2Y15.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.02%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year2.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y10%
OCF growth 3Y9.02%
OCF growth 5Y29.8%